News | August 26, 2014

New Information on Transcranial Ultrasound Therapy

Transcranial Ultrasound Therapy Oncology

August 26, 2014 — A recent study completed at the University of Eastern Finland provides new information on the limitations and potential new directions for the future development of transcranial ultrasound therapy. Active research is taking place in the field of transcranial ultrasound therapy, which in the future can potentially be applied to the treatment of brain tumors and targeted drug delivery. The therapy modality has already been successfully applied to the treatment of neuropathic pain disorder and essential tremors. The benefits of transcranial ultrasound therapy include minimal invasiveness, as the treatment is delivered to the brain by transmitting ultrasound through the intact skull of the patient. The study focuses on two issues that may potentially limit the applicability of transcranial ultrasound: skull-base heating and formation of standing-waves.

Skull-base Heating Must be Taken Into Account in Treatment Planning

As the ultrasound beam encounters the skull bone, part of the beam's energy is transferred into the skull as heat. In the study, it was found that the heating of the skull-base during transcranial ultrasound therapy can result in hazardous temperature elevations when the sonications are performed close to the skull-base. Three new methods to counteract this potentially hazardous phenomenon were developed in the study.

Standing waves, on the other hand, are formed in the ultrasound field when waves reflect from the surface of the skull bone. During transcranial ultrasound therapy, the ultrasound amplitude can reach higher levels than intended if these reflections are not taken into account during the initial treatment planning. The study found that the formation of standing waves is greatly reduced when specifically designed large-area ultrasound transducers are used.

A Numerical Method to Simulate Propagation of Ultrasound

The study also introduces a model to numerically simulate clinical patient treatments performed with transcranial ultrasound therapy. The predictions produced by the model were compared to observations done in clinical patient trials performed earlier. The predictions were found to be of an adequate accuracy for an initial treatment planning. However, more accurate characterization of the acoustical and thermal parameters involved in transcranial ultrasound therapy are nevertheless needed.

For more information: epublications.uef.fi/pub/urn_isbn_978-952-61-1510-8/urn_isbn_978-952-61-1510-8.pdf

Related Content

Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Insightec Announces Expanded Reach of MR-Guided Focused Ultrasound
News | Focused Ultrasound Therapy | August 22, 2017
Insightec announced recently that worldwide adoption of magnetic resonance (MR)-guided focused ultrasound continues to...
U.S. Clinical Data Supports Echotherapy With Echopulse for Breast Fibroadenomas
News | Focused Ultrasound Therapy | May 04, 2017
Theraclion recently announced the presentation of data from the U.S. feasibility trial of echotherapy with Echopulse, a...
First Focused Ultrasound Surgery Performed on Hypothalamic Hamartoma Tumor in Epilepsy Patient
News | Focused Ultrasound Therapy | April 21, 2017
A multidisciplinary clinical team at Nicklaus Children's Hospital used magnetic-resonance guided focused ultrasound – a...
News | Focused Ultrasound Therapy | April 12, 2017
Theraclion announced results of a study evaluating the long-term assessment of breast fibroadenoma (benign tumor)...
high-intensity focused ultrasound, HIFU, prostate tissue ablation, after radiotherapy, EDAP TMS SA, Ablatherm, British Journal of Urology International study
News | Focused Ultrasound Therapy | March 29, 2017
EDAP TMS SA announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU (high-intensity...
brain FUS

Brain FUS uses an array of about 1,000 elements designed to overcome attenuation issues presented by the skull and to diffuse the heating over a large area of the brain to prevent damaging healthly tissue. 

Feature | Radiation Oncology | March 02, 2017 | By Dave Fornell
Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), has gained a lot of interest in recent...
insightec exablate high intensity focused ultrasound system

The InSightec ExAblate focused ultrasound system developed to treat essential tremor. Studies are underway to see if FUS can be used to treat other brain conditions and brain cancer.

Feature | Focused Ultrasound Therapy | February 03, 2017 | Dave Fornell
Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), has gained a lot of interest in recent...
MRgFUS
News | Focused Ultrasound Therapy | January 17, 2017
Insightec, a leader in MR-guided focused ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of...
Overlay Init